ATE231725T1 - Pharmazeutische zubereitungen zur oralen verabreichung von molekulares jod - Google Patents

Pharmazeutische zubereitungen zur oralen verabreichung von molekulares jod

Info

Publication number
ATE231725T1
ATE231725T1 AT98954002T AT98954002T ATE231725T1 AT E231725 T1 ATE231725 T1 AT E231725T1 AT 98954002 T AT98954002 T AT 98954002T AT 98954002 T AT98954002 T AT 98954002T AT E231725 T1 ATE231725 T1 AT E231725T1
Authority
AT
Austria
Prior art keywords
iodine
mammal
molecular iodine
molecular
oral administration
Prior art date
Application number
AT98954002T
Other languages
English (en)
Inventor
Yongjun Duan
John Hickey
Rick Panicucci
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Application granted granted Critical
Publication of ATE231725T1 publication Critical patent/ATE231725T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98954002T 1997-10-29 1998-10-27 Pharmazeutische zubereitungen zur oralen verabreichung von molekulares jod ATE231725T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine
PCT/US1998/022720 WO1999021567A1 (en) 1997-10-29 1998-10-27 Pharmaceutical compositions for oral administration of molecular iodine

Publications (1)

Publication Number Publication Date
ATE231725T1 true ATE231725T1 (de) 2003-02-15

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98954002T ATE231725T1 (de) 1997-10-29 1998-10-27 Pharmazeutische zubereitungen zur oralen verabreichung von molekulares jod

Country Status (17)

Country Link
US (1) US5885592A (de)
EP (1) EP1024815B1 (de)
JP (1) JP4187410B2 (de)
KR (1) KR100412219B1 (de)
CN (1) CN1150904C (de)
AT (1) ATE231725T1 (de)
AU (1) AU750627B2 (de)
BR (1) BR9812588A (de)
CA (1) CA2301503C (de)
DE (1) DE69811105T2 (de)
DK (1) DK1024815T3 (de)
ES (1) ES2191973T3 (de)
IL (1) IL134778A0 (de)
NO (1) NO20001673L (de)
PT (1) PT1024815E (de)
RU (1) RU2213564C2 (de)
WO (1) WO1999021567A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
WO1999034809A1 (fr) * 1998-01-06 1999-07-15 Fujisawa Pharmaceutical Co., Ltd. Preparations solides a base d'iodophore et procede de fabrication correspondant
DE69910210T2 (de) 1998-06-19 2004-06-17 Oxibio, Inc., Portland Implantierbare medizinische vorrichtung mit antiinfektiösen und kontrazeptiven eigenschaften
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
PT1195178E (pt) * 2000-10-06 2006-10-31 Dmg Italia Srl Preparacao imunotrofica para o tratamento da hipertrofia adenoamigdalar.
ES2359818T3 (es) * 2003-06-20 2011-05-27 Hill's Pet Nutrition, Inc. Métodos para hipertiroidismo en un gato y composición que comprende yodo limitado.
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
CA2823751C (en) * 2006-01-26 2015-10-06 Hill's Pet Nutrition, Inc. Methods and compositions for treating feline hyperthyroidism
CA2650845C (en) * 2006-05-12 2015-07-07 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
CA2656608C (en) * 2006-07-03 2014-09-16 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
EP2606885B1 (de) * 2011-05-16 2016-05-11 Begaliev, Shokan Sabirkhanovich Wiederherstellung eines arzneimittelpräparats mit antibakterieller, antiulzeröser und immunmodulierender wirkung
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技（潍坊）有限公司 一种固态分子碘消毒制剂及其制备方法
US10034899B2 (en) * 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
JP6573620B2 (ja) * 2014-02-10 2019-09-11 フレッド ハッチンソン キャンサー リサーチ センター 心臓発作及び虚血損傷のハロゲン治療
WO2015153258A1 (en) 2014-03-31 2015-10-08 Iotech International, Llc Stable compositions of uncomplexed iodine and methods of use
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая
WO2017185060A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
KR20190123716A (ko) 2016-07-21 2019-11-01 아이오젠, 엘엘씨 연화성 국소 소독제
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
TW202203900A (zh) * 2020-03-31 2022-02-01 越南商泰明製藥股份有限公司 用於治療癌症、子宮內膜異位症以及癌症或子宮內膜異位症患者的疼痛之二異丙胺化合物以及碘

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Also Published As

Publication number Publication date
RU2213564C2 (ru) 2003-10-10
BR9812588A (pt) 2000-07-25
WO1999021567A1 (en) 1999-05-06
IL134778A0 (en) 2001-04-30
CN1272789A (zh) 2000-11-08
US5885592A (en) 1999-03-23
CA2301503A1 (en) 1999-05-06
ES2191973T3 (es) 2003-09-16
JP4187410B2 (ja) 2008-11-26
EP1024815B1 (de) 2003-01-29
DE69811105D1 (de) 2003-03-06
AU750627B2 (en) 2002-07-25
DE69811105T2 (de) 2003-11-06
CA2301503C (en) 2005-01-04
NO20001673D0 (no) 2000-03-31
NO20001673L (no) 2000-05-24
AU1122799A (en) 1999-05-17
CN1150904C (zh) 2004-05-26
JP2003510243A (ja) 2003-03-18
EP1024815A1 (de) 2000-08-09
KR20010030861A (ko) 2001-04-16
DK1024815T3 (da) 2003-05-19
KR100412219B1 (ko) 2003-12-24
PT1024815E (pt) 2003-06-30

Similar Documents

Publication Publication Date Title
ATE231725T1 (de) Pharmazeutische zubereitungen zur oralen verabreichung von molekulares jod
PL350658A1 (en) Medical preparations for the treatment of alpha−galactosidase a deficiency
ATE306266T1 (de) Verbesserte verabreichungstechnik für multiple medikamentengaben
IL208184A0 (en) Glp-1, and methods for treating diabetes
ATE319447T1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
ATE277594T1 (de) Vorrichtungen um eine verlängerte medikamententherapie zu erreichen
DE60324427D1 (de) Verfahren zur modulation der tubulindeacetylase-aktivität
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
PL345959A1 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
DE69619052D1 (de) Feste, wasserfreie, pharmazeutische Zubereitungen für vaginale Verwendung
UA32457C2 (uk) Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм
PT1007055E (pt) Utilizacao de amifostina
DK0996462T3 (da) Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner
CA2032475A1 (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
EP0835662A3 (de) Arzneimittel zur Behandlung von Krebs
EP1073436A4 (de) Verbesserte methode zur ausrottung von helicobacter pylori
EP0271151A3 (de) Azumolen-Dosisformen
DK1019066T3 (da) Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand
CA2197139A1 (en) A drug for the treatment of cancer
RU97101420A (ru) Способ лечения тонзиллита
HK1056117A1 (en) Treatment of hepatitis C with thymosin and pegylated interferon
RU97110400A (ru) Способ профилактики и лечения больных, страдающих эстрогенно- и андрогенозависимыми опухолями
RU97104198A (ru) Способ лечения респираторного дистресс-синдрома

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1024815

Country of ref document: EP

REN Ceased due to non-payment of the annual fee